Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy

Background. Chemoimmunotherapy has become the first-line treatment for unresectable esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients who could benefit from this combined therapy remain uncertain. This study focused on elucidating the predictive significance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaolu, Ding, Yongfeng, Qian, Jiong, Wan, Mingyu, Li, Ning, Mao, Chenyu, Xiao, Cheng, Jiang, Haiping, Zheng, Yulong, Wu, Luntao, Chen, Xiaoyu, Xu, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689525/
https://www.ncbi.nlm.nih.gov/pubmed/36421355
http://dx.doi.org/10.3390/curroncol29110702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689525/
https://www.ncbi.nlm.nih.gov/pubmed/36421355
http://dx.doi.org/10.3390/curroncol29110702

Ejemplares similares